RESUMO
Instabilidade elétrica atrial é um termo recentemente incorporado na prática médica para descrever o amplo espectro de arritmias atriais que se sobrepõem. Essa relação já era intuitiva entre flutter atrial e fibrilação atrial (que deu berço ao anteriormente chamado "fibrilo-flutter"), e, mais recentemente, associou taquicardias atriais e fibrilação atrial. Essa relação é de suma importância, posto que o diagnóstico de fibrilação atrial implica estratégias para prevenção de eventos embólicos. Com novos métodos de rastreio, o diagnóstico de fibrilação atrial se mostrou mais frequente (monitorização prolongada, monitores implantáveis, telemetria de marcapassos). A presença de extrassistolia atrial e taquicardia atrial se torna um desafio: apesar da relação intuitiva de maior risco para fibrilação atrial e eventos cerebrovasculares, a evidência científica para tal se tornou mais robusta recentemente. Este artigo tem a intenção de agregar a evidência de melhor qualidade disponível para facilitar a seleção da estratégia adequada ante um paciente portador de taquicardia e extrassistolia atrial e avaliar adequadamente seu risco
Atrial electrical instability is a recently incorporated term in medical practice to describe the broad spectrum of overlapping atrial arrhythmias. This relationship was already intuitive between atrial flutter and atrial fibrillation (which gave birth to the so-called "fibril-flutter"), and has more recently been related to atrial tachycardias and atrial fibrillation. This relationship is extremely important, since the diagnosis of atrial fibrillation implies in strategies to prevent embolic events. With new screening methods, the diagnosis of atrial fibrillation has become more frequent (prolonged monitoring, implantable monitors, pacemaker telemetry). The presence of atrial extrasystoles and atrial tachycardia is a challenge: despite the intuitive relationship of higher risk for atrial fibrillation and cerebrovascular events, the scientific evidence became more robust recently. This article intends to aggregate the best quality evidence available to facilitate the choice of an appropriate strategy for a patient with tachycardia and atrial extrasystoles and to adequately assess their risk
Assuntos
Humanos , Masculino , Feminino , Arritmias Cardíacas/diagnóstico , Fibrilação Atrial , Taquicardia Atrial Ectópica/diagnóstico , Nó Atrioventricular , Fatores de Risco , Complexos Atriais Prematuros/etiologia , Eletrocardiografia/métodos , Coração , Átrios do Coração , Antiarrítmicos/uso terapêutico , Anticoagulantes/uso terapêuticoRESUMO
As taquiarritmias atriais representam um grupo heterogêneo de arritmias dentro das taquicardias supraventriculares, que apresentam como característica comum a ausência do nó atrioventricular como parte integrante do circuito destas arritmias. Dentre elas, destacam-se as taquicardias atriais, que podem ser focais ou macrorreentrantes. O eletrocardiograma é uma ferramenta importante nesta diferenciação, assim como o estudo eletrofisiológico, valendo-se de técnicas de mapeamento eletroanatômico (MEA), cada vez mais apuradas para este diagnóstico. As taquicardias atriais focais representam especial desafio diagnóstico e terapêutico. Padrões eletrocardiográficos, avaliação dos padrões da arritmia durante monitorização eletrocardiográfica prolongada, avaliação dos padrões de resposta a fármacos e avaliação da ativação atriale da resposta a manobras durante estudo eletrofisiológico constituem a base do seu diagnóstico. Com o desenvolvimento de novas técnicas e taxas de sucesso crescente, a ablação por radiofrequência tem se tornado, nos últimos anos, o tratamento de escolha para pacientes com taquicardia atrial focal sintomática, especialmente nos casos de taquicardia atrial incessante, pelo risco potencial de desenvolvimento de taquicardiomiopatia. Este artigo tem por objetivo realizar revisão da literatura quanto aos aspectos mais atuais no diagnóstico e tratamento das principais taquiarritmias atriais...
Atrial tachyarrhythmias are a heterogeneous group within the supraventricular tachycardia group that share in common the absence of the atrioventricular node as an integral componente of the arrhythmia circuit. Among them, special attention is given to atrial tachycardias (AT), which may present as focal or macroreentrant. The electrocardiogram (EKG) is an important tool in this differentiation, as is the electrophysiological study using techniques of electroanatomical mapping (EAM), both of which are becoming increasingly accurate in this diagnosis. The diagnosis and treatment of focal atrial tachycardias are challenging. The diagnosis is based on electrocardiographic patterns, evaluation of the patterns of arrhythmia during prolonged electrocardiographic monitoring, evaluation of the patterns of response to drugs, and evaluation of the atrial activation and the response to maneuvers during electrophysiological testing. With the development of new techniques, and the increasing success rates, radiofrequency ablation (RFA) has become the gold standard therapy in recent years for patients with symptomatic focal atrial tachycardia, particularly in cases of incessant atrial tachycardia, due to the potential risk for the development of tachycardia-induced cardiomyopathy.The objective of this article is to present a review of the literature, emphasizing the current aspects of diagnosis and therapy for atrial tachyarrhythmias...
Assuntos
Humanos , Taquicardia Atrial Ectópica/diagnóstico , Taquicardia Atrial Ectópica/terapia , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/terapia , Átrios do Coração , Ablação por Cateter/métodos , Arritmias Cardíacas/diagnóstico , Arritmias Cardíacas/terapia , Diagnóstico Diferencial , Eletrocardiografia Ambulatorial/métodos , Eletrocardiografia/métodos , Eletrofisiologia/métodos , Frequência CardíacaRESUMO
Cardiac arrhythmias often present as urgent medical conditions requiring immediate care. Patient presenting with a tachyarrhythmia is a common finding in the emergency room. They also occur commonly in patients undergoing non-cardiovascular procedures including surgeries. It is thus pertinent that the physician handling such cases must be appropriately trained to diagnose and provide emergency management till the case is referred to a specialist. Most cases present as narrow or a wide complex tachycardia. The differential diagnosis is arrived at by deciding on the ECG morphology alongwith relevant history and physical examination where feasible. This article describes the bedside approach to diagnose and treat an arrhythmia presenting as a narrow complex.
Assuntos
Antagonistas Adrenérgicos beta/efeitos adversos , Fibrilação Atrial/diagnóstico , Bloqueadores dos Canais de Cálcio/efeitos adversos , Diagnóstico Diferencial , Cardioversão Elétrica , Eletrocardiografia , Serviço Hospitalar de Emergência , Humanos , Taquicardia Atrial Ectópica/diagnósticoRESUMO
Of the various therapeutic modalities available to treat ectopic atrial tachycardia, radiofrequency catheter ablation has shown excellent results. It is usually possible to localize the earliest site of endocardial activation by conventional or newer three-dimensional mapping techniques. We report a case of ectopic atrial tachycardia, wherein the tachycardia was being repeatedly interrupted by mechanical trauma. Finally, with the help of P wave pace mapping, the tachycardia was localized near the posterolateral part of the mitral annulus, and successfully ablated. This report demonstrates the utility of P wave pace mapping in ectopic atrial tachycardia.
Assuntos
Adolescente , Estimulação Cardíaca Artificial , Ablação por Cateter , Humanos , Masculino , Taquicardia Atrial Ectópica/diagnósticoRESUMO
Ten patients (aged 0-9 years) with the diagnosis of automatic atrial tachycardia (AAT) from August 1997 to August 2000 were reviewed. Three patients had paroxysmal (repetitive) AAT and the tachycardia was incessant in six (defined as presence of AAT for more than 90% of the time). The type of AAT in one patient was unknown. Four patients presented with congestive heart failure (CHF), one with pre-syncope, one with palpitation, and four were asymptomatic. Six patients (60%) had depressed left ventricular ejection fraction. All patients with CHF had incessant AAT with atrial rate > 220/min and ventricular rate > 200/min at admission. After treatment with antiarrhythmic medications, all patients had adequate control of the AAT (9 had complete elimination of AAT and 1 partial control). Amiodarone (alone, or in combination with digoxin) was effective in 5 of 6 cases (83%), although complete elimination of the AAT was usually delayed (median = 5 days, range 30 minutes to 17 days). Other effective medications were digoxin, digoxin + propranolol and atenolol (all in patients who did not have CHF on presentation). At the time of this report, 3 patients had no AAT off antiarrhythmic medication, 5 patients were still receiving treatment (with good control) and 2 patients died from sepsis during the same admission even though AAT was controlled. All surviving patients had normal ventricular ejection fraction on follow-up. AAT in children is rare, but when it occurs in persistent form at a fast rate, it is usually associated with CHF and is difficult to treat. Amiodarone (+/- digoxin) effectively controls the arrhythmia in the majority of cases, although full effect may take several days. With successful treatment, most patients do well and some can be taken off the medication(s) without recurrence of the arrhythmia.
Assuntos
Adolescente , Fatores Etários , Antiarrítmicos/administração & dosagem , Criança , Pré-Escolar , Estudos de Coortes , Eletrocardiografia , Feminino , Testes de Função Cardíaca , Humanos , Lactente , Recém-Nascido , Masculino , Probabilidade , Prognóstico , Medição de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Análise de Sobrevida , Taquicardia Atrial Ectópica/diagnóstico , Tailândia , Resultado do TratamentoRESUMO
Two hundred and one consecutive patients with symptomatic paroxysmal supraventricular tachycardia (PSVT) underwent a diagnostic electrophysiological test and catheter ablation with radiofrequency (RF) current. In 102 (51%) patients, the mechanism of PSVT was found to be atrioventricular nodal reentry (AVNRT, typical in 101, atypical in 1). Atrioventricular reentrant tachycardia (AVRT) involving accessory pathway was present in 94 (47%) and ectopic atrial tachycardia in 5 patients. A successful outcome was achieved in 100 of 102 patients (98%) with AVNRT and in 85 of 94 patients (90%) with AVRT. The anatomical approach was used for ablation in patients with AVNRT. The focus was ablated in 4 patients with ectopic atrial tachycardia whereas it was modified in the remaining one patient. Procedure-related complications occurred in 4 patients (2 AVNRT, 2 AVRT). One patient each developed haemothorax, pericardial effusion, mitral valve endocarditis and high-grade AV block requiring permanent pacemaker implantation. The electrode and ablation catheters were repeatedly used after ethylene oxide sterilisation to reduce the cost of the procedure. RF ablation is an effective, safe and curative modality of treatment for patients with symptomatic PSVT due to AVNRT and AVRT. The experience with this modality in patients with ectopic atrial tachycardia is limited.
Assuntos
Adolescente , Adulto , Idoso , Ablação por Cateter , Criança , Eletrofisiologia , Estudos de Avaliação como Assunto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Taquicardia por Reentrada no Nó Atrioventricular/diagnóstico , Taquicardia Atrial Ectópica/diagnóstico , Taquicardia por Reentrada no Nó Sinoatrial/diagnóstico , Taquicardia Supraventricular/diagnósticoRESUMO
La taquicardia auricular es una causa de taquicardia paroxística supraventricular que puede originarse en relación a un circuito de reentrada intraauricular o por la existencia de uno o múltiples focos de automatismo anormal. Esta última forma de taquicardia se denomina como taquicardia auricular ectópica (TAE) y se caracteriza porque suele ser resistente a tratamiento antirrítmico y porque en caso de tener carácter incesante puede llevar a insuficiencia cardíaca. En los últimos años se han desarrollado diversas alternativas de tratamiento no farmacológico. En la presente publicación presentamos el caso clínico de una mujer con TAE derecha que fue fulgurada con radiofrecuencia en forma exitosa
Assuntos
Humanos , Feminino , Gravidez , Adulto , Ablação por Cateter/métodos , Eletrocoagulação/métodos , Taquicardia Atrial Ectópica/cirurgia , Atenolol/uso terapêutico , Diagnóstico Diferencial , Eletrocardiografia , Eletrofisiologia , Veia Femoral/fisiologia , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Taquicardia Atrial Ectópica/diagnóstico , Taquicardia Atrial Ectópica/tratamento farmacológico , Taquicardia Atrial Ectópica/etiologia , Taquicardia Paroxística/complicaçõesRESUMO
A 8-year-old female patient with refractory incessant atrial tachycardia, very symptomatic and with left ventricular ejection fraction of 0.25. Electrophysiological study and endocardial mapping localized the site of the origin of atrial tachycardia in the superior right atrium. In this site 2 applications of radiofrequency current (25V, 20 and 50 seconds) resulted in termination of the atrial tachycardia. She was discharged off antiarrhythmic drugs and after 2 months ejection fraction was 0.52. She was completely asymptomatic 6 months after ablation procedure
Paciente de 8 anos com história de taquicardia atrial ectópica incessante e refratária a drogas antiarrítmicas, muito sintomática e tendo grande comprometimento da função ventricular, com fração de ejeção de 0,25. A paciente foi submetida a estudo eletrofisiológico e ao mapeamento endocárdico que localizou o foco da taquicardia na regino superior do átrio direito, observando-se precocidade de 40ms do eletrograma nesse local em relação à onda P do eletrocardiograma de superfície. Nesta região foram feitas 2 aplicações de radiofreqüência de 25V com 20 e 50s de duração, com desaparecimento da taquicardia. A paciente evoluiu sem arritmia e após 2 meses a fração de ejeção era de 0,52. Atualmente, encontra-se assintomática após 6 meses de acompanhamento ambulatorial